RecallDepth
Class II Ongoing

Clorazepate Dipotassium Tablets, USP, 7.5 mg, a) 100 tablets per bottle, NDC 13107-283-01, b) 500 tablets per bottle, NDC 13107-283-05, Rx Only, Distributed by Aurobindo Pharma USA, Inc., 279 Princeton-Hightstown Road, East Windsor, NJ 08520, Made in India.

This recall is currently active, issued May 15, 2024. It was issued by Aurobindo Pharma Usa Inc..

Company
Aurobindo Pharma Usa Inc.
Recall Initiated
April 24, 2024
Posted
May 15, 2024
Recall Number
D-0492-2024
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
6909 bottles
Firm Location
East Windsor, NJ, United States
Official Source
View on FDA website ↗

Reason for Recall

Discoloration: Dotted and yellow spots on tablets

Distribution

Nationwide in the USA

Lot / Code Info

Lot #s: a) CZB124001B, CZB124002B, CZB124003B, Exp. 12/31/2025; b) CZB124001A, CZB124003A, Exp. 12/31/2025.

More recalls by Aurobindo Pharma Usa Inc.

View all recalls by this company →

Other recent Class II Drug recalls